ITC: Study provides first evidence of paclitaxel benefit for anaplastic thyroid cancer

LAKE BUENA VISTA, FLA. – Weekly infusions of paclitaxel delayed progression in some patients with the very aggressive anaplastic thyroid cancer, a small prospective study determined.

The drug was...